Inhibitory Antibodies

Anti-Human CD3ExBCMA (Elranatamab;PF-06863135)

Anti-Human Her2 (Trastuzumab Deruxtecan; T-DXd)

98+%

Anti-Human CTLA4xLAG3 Bispecific Antibody ( Bavunalimab; XmAb-22841;cytotoxic T-lymphocyte-associated protein 4, CD152;lymphocyte activating 3, lymphocyte-activation 3, CD223)

95+%

Anti-Human PD-1xCTLA-4 Bispecific Antibody(Vudalimab；XmAb-20717,cytotoxic T-lymphocyte-associated protein 4, CD152;programmed cell death 1, PD1, PD-1, CD279)

95+%

Anti-Human CD3xGPRC5D Bispecific Antibody ( Talquetamab； JNJ-64407564； JNJ-7564)

95+%

Anti-Human CD3xClaudin18.2 Bispecific Antibody ( Gresonitamab； AMG 910; )

95+%

Anti-Human CD3ExCD20 Bispecific Antibody(Odronextamab)

95+%

Anti-Human CD3ExCD20 (Epcoritamab; GEN3013)

95+%

Anti-Human EGFRxMET Bispecific Antibody(Amivantamab; JNJ-61186372)

95+%

Anti-Human CD3xBCMA Bispecific Antibody(Teclistamab )

95+%

Anti-Human CD3xCEACAM5 Bispecific Antibody(Cibisatamab)

95+%

Anti-Human VEGFAxANGPT2 (Faricimab; RG7716)

95+%

Anti-Human Her2xHer3 (Zenocutuzumab; MCLA-128; PB4188; R040517)

95+%

Anti-Human CD3xCD20 Bispecific Antibody (Mosunetuzumab; BTCT-4465A； R07030816；CD20-TDB; RG7828; CD20 CD3 bispecific antibody.)

95+%

Anti-Human F9xF10 Bispecific Antibody(Emicizumab；RO 5534262, ACE 910；RG6013,hBS910;coagulation factor 10, coagulation factor X;coagulation factor 9, coagulation factor IX)

95+%

Anti-Human IGF1RxHer3 Bispecific Antibody (Istiratumab; MM 141; MM-005)

95+%

Anti-Human CD3xCD19 Bispecific Antibody(Blinatumomab; Blincyto; MT103; MEDI-538; MEDI 538; Anti-human CD3 CD19; Human CD3 CD19 bispecific)

95+%

Anti-Human CD3xCD20 (Synonyms: Glofitamab; RO7082859; CD20-TCB ,RG-6026;CD3e, CD3 epsilon;membrane-spanning 4-domains subfamily A member 1, CD20,MS4A1)

95+%

Anti-Human ANGPTL3 Monoclonal Antibody(Evinacumab)

95+%

Anti-Human IL-1B Monoclonal Antibody(Canakinumab)

95+%